Does the media refer more to AIRS or NAKA?

In the previous week, AirSculpt Technologies and AirSculpt Technologies both had 2 articles in the media. AirSculpt Technologies' average media sentiment score of 1.87 beat KindlyMD's score of 1.31 indicating that AirSculpt Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AirSculpt Technologies 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, LFMD or NAKA?

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $193.33M 0.93 $14.35M $0.05 74.20 KindlyMD $1.82M 46.56 -$52.23M -$43.20 N/A

Is LFMD or NAKA more profitable?

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 2.37% -150.88% -22.59% KindlyMD -7,397.12% -81.32% -54.17%

Does the media refer more to LFMD or NAKA?

In the previous week, LifeMD had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for LifeMD and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat LifeMD's score of 0.51 indicating that KindlyMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, BDSX or NAKA?

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $96.10M 2.37 -$35.26M -$4.06 N/A KindlyMD $1.82M 46.56 -$52.23M -$43.20 N/A

Is BDSX or NAKA more profitable?

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -33.26% -2,101.40% -35.65% KindlyMD -7,397.12% -81.32% -54.17%

Does the media refer more to BDSX or NAKA?

In the previous week, Biodesix had 3 more articles in the media than KindlyMD. MarketBeat recorded 5 mentions for Biodesix and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat Biodesix's score of 0.98 indicating that KindlyMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodesix 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, NAKA or XGN?

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 46.56 -$52.23M -$43.20 N/A Exagen $68.38M 1.65 -$19.95M -$0.89 N/A

Is NAKA or XGN more profitable?

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -7,397.12% -81.32% -54.17% Exagen -29.49% -94.37% -28.96%

Does the media favor NAKA or XGN?

In the previous week, Exagen had 1 more articles in the media than KindlyMD. MarketBeat recorded 3 mentions for Exagen and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat Exagen's score of 0.63 indicating that KindlyMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exagen 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BNR or NAKA?

KindlyMD has a consensus target price of $30.00, suggesting a potential upside of 516.02%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KindlyMD 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Does the media prefer BNR or NAKA?

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. Burning Rock Biotech's average media sentiment score of 1.68 beat KindlyMD's score of 1.31 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive KindlyMD 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

KindlyMD (NAKA) Competitors

$4.87 -0.10 (-2.01%)

As of 07/24/2026 04:00 PM Eastern

Compare

NAKA vs. AIRS, LFMD, BDSX, XGN, and BNR

Should you buy KindlyMD stock or one of its competitors? MarketBeat compares KindlyMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KindlyMD include AirSculpt Technologies (AIRS), LifeMD (LFMD), Biodesix (BDSX), Exagen (XGN), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry.

How does KindlyMD compare to AirSculpt Technologies?

AirSculpt Technologies (NASDAQ:AIRS) and KindlyMD (NASDAQ:NAKA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

91.5% of AirSculpt Technologies shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 24.5% of KindlyMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AirSculpt Technologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, KindlyMD has a beta of 16.05, indicating that its stock price is 1,505% more volatile than the broader market.

In the previous week, AirSculpt Technologies and AirSculpt Technologies both had 2 articles in the media. AirSculpt Technologies' average media sentiment score of 1.87 beat KindlyMD's score of 1.31 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AirSculpt Technologies	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AirSculpt Technologies presently has a consensus price target of $4.50, suggesting a potential downside of 2.39%. KindlyMD has a consensus price target of $30.00, suggesting a potential upside of 516.02%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts clearly believe KindlyMD is more favorable than AirSculpt Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

AirSculpt Technologies has higher revenue and earnings than KindlyMD. AirSculpt Technologies is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.84M	2.14	-$11.67M	-$0.17	N/A
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A

AirSculpt Technologies has a net margin of -7.39% compared to KindlyMD's net margin of -7,397.12%. AirSculpt Technologies' return on equity of -4.98% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
KindlyMD	-7,397.12%	-81.32%	-54.17%

Summary

AirSculpt Technologies beats KindlyMD on 9 of the 15 factors compared between the two stocks.

How does KindlyMD compare to LifeMD?

LifeMD (NASDAQ:LFMD) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

LifeMD currently has a consensus price target of $9.14, indicating a potential upside of 146.44%. KindlyMD has a consensus price target of $30.00, indicating a potential upside of 516.02%. Given KindlyMD's higher probable upside, analysts clearly believe KindlyMD is more favorable than LifeMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	2 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.60
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

LifeMD has a beta of 1.99, indicating that its share price is 99% more volatile than the broader market. Comparatively, KindlyMD has a beta of 16.05, indicating that its share price is 1,505% more volatile than the broader market.

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$193.33M	0.93	$14.35M	$0.05	74.20
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
KindlyMD	-7,397.12%	-81.32%	-54.17%

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 24.5% of KindlyMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, LifeMD had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for LifeMD and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat LifeMD's score of 0.51 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeMD	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

LifeMD beats KindlyMD on 10 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Biodesix?

Biodesix (NASDAQ:BDSX) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Biodesix had 3 more articles in the media than KindlyMD. MarketBeat recorded 5 mentions for Biodesix and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat Biodesix's score of 0.98 indicating that KindlyMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Biodesix has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market. Comparatively, KindlyMD has a beta of 16.05, indicating that its stock price is 1,505% more volatile than the broader market.

Biodesix presently has a consensus target price of $28.33, indicating a potential upside of 28.79%. KindlyMD has a consensus target price of $30.00, indicating a potential upside of 516.02%. Given KindlyMD's higher possible upside, analysts clearly believe KindlyMD is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-33.26%	-2,101.40%	-35.65%
KindlyMD	-7,397.12%	-81.32%	-54.17%

21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by insiders. Comparatively, 24.5% of KindlyMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$96.10M	2.37	-$35.26M	-$4.06	N/A
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A

Summary

Biodesix beats KindlyMD on 9 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Exagen?

KindlyMD (NASDAQ:NAKA) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

KindlyMD has a beta of 16.05, meaning that its share price is 1,505% more volatile than the broader market. Comparatively, Exagen has a beta of 2.02, meaning that its share price is 102% more volatile than the broader market.

In the previous week, Exagen had 1 more articles in the media than KindlyMD. MarketBeat recorded 3 mentions for Exagen and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.31 beat Exagen's score of 0.63 indicating that KindlyMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Exagen	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of Exagen shares are held by institutional investors. 24.5% of KindlyMD shares are held by insiders. Comparatively, 10.4% of Exagen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

KindlyMD presently has a consensus price target of $30.00, suggesting a potential upside of 516.02%. Exagen has a consensus price target of $9.11, suggesting a potential upside of 94.68%. Given KindlyMD's higher probable upside, research analysts plainly believe KindlyMD is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.90

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A
Exagen	$68.38M	1.65	-$19.95M	-$0.89	N/A

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
Exagen	-29.49%	-94.37%	-28.96%

Summary

Exagen beats KindlyMD on 10 of the 17 factors compared between the two stocks.

How does KindlyMD compare to Burning Rock Biotech?

Burning Rock Biotech (NASDAQ:BNR) and KindlyMD (NASDAQ:NAKA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, KindlyMD has a beta of 16.05, indicating that its stock price is 1,505% more volatile than the broader market.

KindlyMD has a consensus target price of $30.00, suggesting a potential upside of 516.02%. Given KindlyMD's stronger consensus rating and higher possible upside, analysts plainly believe KindlyMD is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Comparatively, 24.5% of KindlyMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Burning Rock Biotech has a net margin of -11.57% compared to KindlyMD's net margin of -7,397.12%. Burning Rock Biotech's return on equity of -10.98% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
KindlyMD	-7,397.12%	-81.32%	-54.17%

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 2 articles in the media. Burning Rock Biotech's average media sentiment score of 1.68 beat KindlyMD's score of 1.31 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
KindlyMD	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Burning Rock Biotech has higher revenue and earnings than KindlyMD. Burning Rock Biotech is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$514.43M	0.18	-$7.92M	-$0.82	N/A
KindlyMD	$1.82M	46.56	-$52.23M	-$43.20	N/A

Summary

Burning Rock Biotech beats KindlyMD on 9 of the 15 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$86.49M	$9.51B	$6.87B	$12.26B
Dividend Yield	N/A	1.64%	2.67%	9.79%
P/E Ratio	-0.11	25.73	27.11	23.64
Price / Sales	46.56	26.23	512.89	89.27
Price / Cash	N/A	142.74	50.54	59.64
Price / Book	0.10	6.11	10.28	6.07
Net Income	-$52.23M	$179.69M	$3.60B	$331.99M
7 Day Performance	19.95%	-3.06%	-1.27%	-0.63%
1 Month Performance	23.29%	0.49%	-0.37%	-2.00%
1 Year Performance	-98.89%	9.52%	18.30%	13.62%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	3.8554 of 5 stars	$4.87 -2.0%	$30.00 +516.0%	-98.9%	$86.49M	$1.82M	N/A	N/A	Positive News
AIRS AirSculpt Technologies	0.7757 of 5 stars	$4.15 -1.2%	$4.50 +8.4%	-26.7%	$292.78M	$151.82M	N/A	240	News Coverage Positive News
LFMD LifeMD	2.8611 of 5 stars	$4.57 +1.4%	$9.14 +100.0%	-65.2%	$221.54M	$194.05M	91.64	230	News Coverage
BDSX Biodesix	3.689 of 5 stars	$20.78 -1.7%	$28.33 +36.4%	+163.3%	$215.78M	$88.50M	N/A	220	News Coverage
XGN Exagen	2.7749 of 5 stars	$4.28 +4.7%	$9.11 +112.8%	-35.2%	$103.74M	$66.57M	N/A	220	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors

NAKA vs. AIRS, LFMD, BDSX, XGN, and BNR

How does KindlyMD compare to AirSculpt Technologies?

Summary

How does KindlyMD compare to LifeMD?

Summary

How does KindlyMD compare to Biodesix?

Summary

How does KindlyMD compare to Exagen?

Summary

How does KindlyMD compare to Burning Rock Biotech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KindlyMD (NAKA) Competitors

NAKA vs. AIRS, LFMD, BDSX, XGN, and BNR

How does KindlyMD compare to AirSculpt Technologies?

Do institutionals and insiders have more ownership in AIRS or NAKA?

Which has more risk and volatility, AIRS or NAKA?

Does the media refer more to AIRS or NAKA?

Do analysts recommend AIRS or NAKA?

Which has stronger valuation and earnings, AIRS or NAKA?

Is AIRS or NAKA more profitable?

Summary

How does KindlyMD compare to LifeMD?

Do analysts prefer LFMD or NAKA?

Which has more risk & volatility, LFMD or NAKA?

Which has better valuation and earnings, LFMD or NAKA?

Is LFMD or NAKA more profitable?

Do insiders & institutionals believe in LFMD or NAKA?

Does the media refer more to LFMD or NAKA?

Summary

How does KindlyMD compare to Biodesix?

Does the media refer more to BDSX or NAKA?

Which has more volatility & risk, BDSX or NAKA?

Do analysts prefer BDSX or NAKA?

Is BDSX or NAKA more profitable?

Do institutionals and insiders believe in BDSX or NAKA?

Which has higher earnings & valuation, BDSX or NAKA?

Summary

How does KindlyMD compare to Exagen?

Which has more risk and volatility, NAKA or XGN?

Does the media favor NAKA or XGN?

Do institutionals & insiders have more ownership in NAKA or XGN?

Do analysts prefer NAKA or XGN?

Which has better earnings and valuation, NAKA or XGN?

Is NAKA or XGN more profitable?

Summary

How does KindlyMD compare to Burning Rock Biotech?

Which has more volatility and risk, BNR or NAKA?

Do analysts prefer BNR or NAKA?

Do insiders & institutionals hold more shares of BNR or NAKA?

Is BNR or NAKA more profitable?

Does the media prefer BNR or NAKA?

Which has stronger valuation and earnings, BNR or NAKA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAKA vs. The Competition

KindlyMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools